Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SSPFF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Siriuspoint's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Siriuspoint's regulatory disclosures and financial reporting.
SiriusPoint Ltd. has appointed Sabra R. Purtill to its Board of Directors effective March 25, 2026, as a Class I director serving until the annual general meeting scheduled for May 20, 2026. She brings 40 years of insurance and financial services experience and has held senior roles at AIG, Hartford Financial Services Group, Assured Guaranty and ACE Limited (now Chubb.
The Board determined that Ms. Purtill is an independent director and an “audit committee financial expert”. She will serve on the Audit Committee and the Risk & Capital Management Committee and receive the same compensation as other non‑employee directors. Directors Franklin (Tad) Montross IV and Peter W. H. Tan will not stand for reelection, with their Board and committee service ending after the May 20, 2026 annual meeting; their decision is stated as not due to any disagreement with the company.
SiriusPoint Ltd ownership update: The Vanguard Group filed an amendment disaggregating certain subsidiaries and reports 0 shares beneficially owned of Common Stock, representing 0% of the class. The filing states the change resulted from an internal realignment effective January 12, 2026.
SiriusPoint Ltd. outlined the exit terms for Rob Gibbs, President & Chief Executive Officer of SiriusPoint International Insurance Corporation (publ), following his previously announced departure. SiriusPoint International and Mr. Gibbs signed a Settlement Agreement on March 17, 2026.
Under the agreement, Mr. Gibbs will receive a severance payment of 401,700 GBP, inclusive of payment in lieu of his six‑month notice period, any pro‑rated 2026 bonus entitlement, and contractual severance, paid in 12 equal monthly installments after his last employment day on April 30, 2026. He will not receive a bonus for 2025.
SiriusPoint International will seek to continue his private medical insurance coverage through April 30, 2027 and life assurance coverage through December 31, 2026, and will pay 3,000 GBP in lieu of life assurance for the period from January 1 through April 30, 2027, all subject to applicable taxes and National Insurance. The agreement includes ongoing confidentiality, non‑disparagement, non‑compete and non‑solicitation obligations and a general release of claims by Mr. Gibbs.
SiriusPoint Ltd. is reorganizing its operations into four business areas: Global P&C Programs, Global Reinsurance, Global Accident & Health, and a London Market Specialty division that includes Lloyd’s. The company is combining its North America and International Programs into a single Global P&C Programs division led by Patrick Charles.
The new London Market Specialty division, highlighting the importance of SiriusPoint’s London platform and Syndicate 1945, will be led by David Govrin, who also serves as CEO Global Reinsurance. As part of these changes, Rob Gibbs, President & CEO of SiriusPoint International, will leave the company under a mutual separation agreement based on the Executive Severance Plan. The company furnished a press release as Exhibit 99.1 describing these structural changes and the leadership transition.
Govrin David E. reported acquisition or exercise transactions in this Form 4 filing.
SiriusPoint Ltd Group President David E. Govrin reported an equity award of 315,738 common shares at a stated price of $0.0000 per share. A footnote explains this represents 315,738 Performance Restricted Share Units achieved at 200% of target from a 2023–2025 grant under the SiriusPoint Ltd. 2023 Omnibus Incentive Plan, scheduled to vest on April 14, 2026. Following this award, Govrin directly holds 833,713 common shares, which the disclosure notes includes restricted shares.
SiriusPoint Ltd Group Chief Underwriting Officer Anthony Shapella reported a tax-related share disposition. On February 27, 2026, 2,248 common shares were withheld to cover current tax liabilities tied to the vesting of restricted shares. Following this, he directly owns 39,967 common shares, including restricted shares.
SiriusPoint Ltd reported that Chief Executive Officer Scott Egan acquired 776,096 common shares on February 26, 2026 through a grant/award at a price of $0.00 per share. This reflects performance-based equity compensation rather than an open-market purchase.
A footnote explains the award represents performance restricted share units from a 2023–2025 grant that achieved 200% of target and will vest on April 14, 2026. After this award, Egan directly holds 1,015,179 common shares, and separately reports indirect ownership of 545,083 shares held through Egan Family Investment Ltd.
SiriusPoint Ltd executive Robin Gibbs, CEO of SiriusPoint International, reported an acquisition of 153,988 common shares on a no-cash basis. These shares represent Performance Restricted Share Units earned at 200% of target under a 2023–2025 grant. Following this award, Gibbs holds 234,586 common shares in total, which the company notes include restricted shares. The performance share units are scheduled to vest on April 14, 2026.
SiriusPoint Ltd has had its 8.00% Resettable Fixed Rate Preference Shares, Series B removed from listing and registration on the New York Stock Exchange LLC. The Exchange states it complied with Rule 17 CFR 240.12d2-2 and that the issuer complied with the Exchange's withdrawal requirements.
SiriusPoint Ltd. reports on its 2025 performance as a global specialty insurance and reinsurance underwriter headquartered in Bermuda. The company had common shareholders’ equity of $2.3 billion, total capital of $3.2 billion and total assets of $12.6 billion as of December 31, 2025.
Core underwriting income reached $214.3 million with a combined ratio of 91.7%, slightly better than 2024’s $200.0 million and 91.0%. Gross written premium increased to $3,705.6 million from $3,244.6 million, while net earned premium rose to $2,593.8 million. The business mix continued shifting toward Accident & Health, Casualty and Other Specialties.
Investment results were strong at $271.9 million, driven by $274.8 million of net investment income and minimal net realized and unrealized losses. Service fee income from consolidated MGAs totaled $41.8 million, and the sale of Armada generated a gain of $222.4 million. The group maintains A-/A3 financial strength ratings with positive or stable outlooks.